Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MYC and RNA Polymerase II Binding Near Transcriptional End Sites Regulate the Expression of Functionally-Related Genes.

bioRxiv : the preprint server for biology·2026
Same author

Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Nature·2026
Same author

Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Hepatoblastoma Cell Lines: Past, Present and Future.

Cells·2025
Same author

Obesity-related microbial dysbiosis as a potential modulator of tumour progression.

Access microbiology·2025
Same author

Derivation of Genetically Defined Murine Hepatoblastoma Cell Lines with Angiogenic Potential.

Cancers·2025

Related Experiment Video

Updated: Jul 9, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.6K

Cholesterol esterification and p53-mediated tumor suppression.

Youjun Li1,2, Michael Karin3, Edward V Prochownik4

  • 1Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan 430072, Hubei, China.

Exploration of Targeted Anti-Tumor Therapy
|November 29, 2023
PubMed
Summary

Loss of the tumor suppressor gene TP53 promotes liver cancer in mice by increasing cholesterol ester biosynthesis. Blocking this cholesterol pathway improves treatment outcomes for liver cancers with TP53 mutations.

Keywords:
Hepatocellular carcinomacholesterol esterificationmevalonate pathwayp53 tumor suppressorsterol O-acyltransferase 1

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.2K
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

11.0K

Related Experiment Videos

Last Updated: Jul 9, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.6K
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.2K
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

11.0K

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Disease

Background:

  • The tumor suppressor gene TP53 regulates critical biological processes, including cell metabolism.
  • Cholesterol is essential for cell membranes and serves as a precursor for vital molecules.
  • Excess cholesterol can be stored as cholesterol esters, impacting cellular function.

Purpose of the Study:

  • To investigate the role of p53 in regulating cholesterol metabolism.
  • To determine the impact of p53 loss on hepatocellular carcinoma development.
  • To evaluate therapeutic strategies targeting cholesterol esterification in liver cancer.

Main Methods:

  • Utilized mouse models with TP53 mutations or deletions.
  • Analyzed cholesterol biosynthesis and esterification pathways.
  • Assessed tumor progression and treatment responses.

Main Results:

  • Loss of p53 function led to excessive cholesterol ester biosynthesis in mice.
  • This aberrant cholesterol metabolism promoted hepatocellular carcinoma.
  • Inhibiting cholesterol esterification improved treatment outcomes in relevant mouse models.

Conclusions:

  • p53 plays a crucial role in controlling cholesterol homeostasis.
  • Aberrant cholesterol esterification driven by p53 loss is a key mechanism in hepatocellular carcinoma development.
  • Targeting cholesterol esterification represents a potential therapeutic strategy for liver cancers with TP53 alterations, especially in the context of non-alcoholic fatty liver disease.